I am a medical oncologist with expertise in caring for patients with breast cancer. I obtained my medical degree at Universidade Nova de Lisboa in my home country, Portugal. After that, I moved to the U.S. to continue my training, and I completed my residency and fellowship in Washington D.C., at MedStar Washington Hospital Center. My primary clinical and research interest is in novel therapies and clinical trials for breast cancer, triple negative breast cancer, health disparities, and cancer genetics.
During my training, I developed a clinical trial to evaluate the cardiac safety of HER2 targeted therapies in patients with mildly reduced cardiac function for which I received a Young Investigator Award from the Conquer Cancer Foundation/Breast Cancer Research Foundation. My other projects have focused on studying deleterious BRCA1/2 mutations in African American women who underwent genetic testing for hereditary breast-ovarian cancer and the cardiac toxicity of anthracyclines in women with BRCA1/2 mutations. I am optimist about the future of patients diagnosed with breast cancer as we learn more about the different subtypes of the disease and new drugs with meaningful impact in our patients lives become available.
2013 - Young Investigator Award Conquer Cancer Foundation/American Society of Clinical Oncology
2013 - Lynn Sage Breast Cancer Achievement Award
2011 - Best Resident, Peer Recognition Award, MedStar Georgetown University Hospital/MedStar Washington Hospital Center Internal Medicine Residency Program
2009 - Best Intern 2008-2009, Peer Recognition Award, MedStar Georgetown University Hospital/MedStar Washington Hospital Center Internal Medicine Residency Program